SK Biopharmaceuticals Co., Ltd. (326030.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 9.76T |
| Enterprise Value | 9.5T |
| P/E Ratio | 18.67 |
| PEG Ratio | 1.26 |
| Price/Sales Ratio | 7.39 |
| Price/Book Ratio | 6.71 |
| Enterprise/Revenue | 7.04 |
| Enterprise/EBITDA | 22.95 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.41 |
| Operating Margin | 0.38 |
AD
Management Effectiveness
| Return On Assets | 0.27 |
| Return On Equity | 0.44 |
Income Statement
| Revenue | 706.74B |
| Revenue/Share | 11,850.28 |
| Gross Profit | 651.67B |
| EBITDA | 220.89B |
| Net Income | 266.95B |
| Diluted EPS | 3,408.75 |
Balance Sheet
| Total Cash | 381.87B |
| Total Cash/Share | 4,876.24 |
| Total Debt | 48.83B |
| Total Debt/Equity | 0.05 |
| Current Ratio | 2.72 |
| Book Value Per Share | 13,047.14 |
Price History
| 52-Week Change | -31.46 |
| 52-Week High | 144,100 |
| 52-Week Low | 67,800 |
| Moving Average 50 Days | 78,644 |
| Moving Average 200 Days | 91,304.5 |
Statistics
| Average Volume | 155,788 |
| Shares Outstanding | 78.31M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
